Reducing cisplatin ototoxicity in children: some hope and many questions

Affiliations

Comment

Eric Bouffet. Lancet Oncol. 2017 Jan.

. 2017 Jan;18(1):6-7.

doi: 10.1016/S1470-2045(16)30630-1. Epub 2016 Dec 1.

¹ The Hospital for Sick Children, University of Toronto, Toronto, ON, M5G 1X8, Canada. Electronic address: eric.bouffet@sickkids.ca.

No abstract available

Comment on

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L. Freyer DR, et al. Lancet Oncol. 2017 Jan;18(1):63-74. doi: 10.1016/S1470-2045(16)30625-8. Epub 2016 Dec 1. Lancet Oncol. 2017. PMID: 27914822 Free PMC article. Clinical Trial.